Notice Information
Notice Title
FaR-RMS Trial - Clinical trial database
Notice Description
The FaR-RMS trial (Sponsored by the University of Birmingham) is an Investigator Initiated Trial which is funded by Cancer Research UK and Bayer AG. The funding is contingent upon having a suitably compliant clinical trial database that is active and ready for use by the end of 2021. Funding is provided to support the trial to be compliant with additional regulations. The trial used an existing clinical trial database (also sourced externally) however upon review, the existing clinical trial database is not suitable for the revised scope of the trial. Therefore, a new clinical trial database that is regulatory compliant, is able to be delivered within a tight timeline and fall within budget is required.
Lot Information
Lot 1
The FaR-RMS trial (Sponsored by the University of Birmingham) is an Investigator Initiated Trial which is funded by Cancer Research UK and Bayer AG. The funding is contingent upon having a suitably compliant clinical trial database that is active and ready for use by the end of 2021. Funding is provided to support the trial to be compliant with additional regulations. The trial used an existing clinical trial database (also sourced externally) however upon review, the existing clinical trial database is not suitable for the revised scope of the trial. Therefore, a new clinical trial database that is regulatory compliant, is able to be delivered within a tight timeline and fall within budget is required. The preferred vendor for creating a clinical trial database for this trial is Viedoc TM.Viedoc TM meets the criteria outlined below that are essential for delivering the clinical trial. The company has a track record of delivering clinical trials to registration standard with other academic organisations running clinical trials of this nature (international, paediatric oncology trials with multiple arms) and was independently recommended to the University of Birmingham. Additionally, Viedoc TM is in the process of undergoing a detailed audit of their systems with the University of Birmingham. This is an essential requirement to perform prior to the set-up of an electronic clinical trial database when required for registration standard trials. Viedoc TM have confirmed their ability to deliver the clinical trial database in 2021 and within the budget. The detailed audit of Viedoc TM has also confirmed that it is compliant with the regulations and is therefore suitable for use in the FaR-RMS trial.
Procurement Information
The preferred vendor for creating a clinical trial database for this trial is Viedoc TM.Viedoc TM meets the criteria outlined below that are essential for delivering the clinical trial. The company has a track record of delivering clinical trials to registration standard with other academic organisations running clinical trials of this nature (international, paediatric oncology trials with multiple arms) and was independently recommended to the University of Birmingham. Additionally, Viedoc TM is in the process of undergoing a detailed audit of their systems with the University of Birmingham. This is an essential requirement to perform prior to the set-up of an electronic clinical trial database when required for registration standard trials. Viedoc TM have confirmed their ability to deliver the clinical trial database in 2021 and within the budget. The detailed audit of Viedoc TM has also confirmed that it is compliant with the regulations and is therefore suitable for use in the FaR-RMS trial. The following are detailed reasons for the selection of Viedoc TM as a vendor to provide a clinical trial database for FaR-RMS: * Able to perform a 'rescue' mission and align an existing clinical database that is in use into a single database for the study * Able to deliver a live clinical trial database for the study in 2021 * Qualified by the University of Birmingham as a regulatory compliant clinical trial database * Fall under a maximum budget of PS500,000 for the whole clinical trial database
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-02e92d
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/025023-2021
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Services
- Procurement Method
- Limited
- Procurement Method Details
- Award procedure without prior publication of a call for competition
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
72 - IT services: consulting, software development, Internet and support
-
- CPV Codes
72320000 - Database services
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £500,000 £500K-£1M
Notice Dates
- Publication Date
- 7 Oct 20214 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 3 Oct 20214 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Not Specified
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- UNIVERSITY OF BIRMINGHAM
- Contact Name
- Paul Markham
- Contact Email
- p.markham@bham.ac.uk
- Contact Phone
- Not specified
Buyer Location
- Locality
- BIRMINGHAM
- Postcode
- B15 2TT
- Post Town
- Birmingham
- Country
- England
-
- Major Region (ITL 1)
- TLG West Midlands (England)
- Basic Region (ITL 2)
- TLG3 West Midlands
- Small Region (ITL 3)
- TLG31 Birmingham
- Delivery Location
- TLG West Midlands (England)
-
- Local Authority
- Birmingham
- Electoral Ward
- Edgbaston
- Westminster Constituency
- Birmingham Edgbaston
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-02e92d-2021-10-07T11:57:53+01:00",
"date": "2021-10-07T11:57:53+01:00",
"ocid": "ocds-h6vhtk-02e92d",
"description": "The standstill period for this VEAT notice will expire at midnight at the end of Monday 18th October 2021.",
"initiationType": "tender",
"tender": {
"id": "SC9502/21",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "FaR-RMS Trial - Clinical trial database",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "72320000",
"description": "Database services"
},
"additionalClassifications": [
{
"scheme": "CPVS",
"id": "72320000-LA23",
"description": "For medical use"
}
],
"mainProcurementCategory": "services",
"description": "The FaR-RMS trial (Sponsored by the University of Birmingham) is an Investigator Initiated Trial which is funded by Cancer Research UK and Bayer AG. The funding is contingent upon having a suitably compliant clinical trial database that is active and ready for use by the end of 2021. Funding is provided to support the trial to be compliant with additional regulations. The trial used an existing clinical trial database (also sourced externally) however upon review, the existing clinical trial database is not suitable for the revised scope of the trial. Therefore, a new clinical trial database that is regulatory compliant, is able to be delivered within a tight timeline and fall within budget is required.",
"lots": [
{
"id": "1",
"description": "The FaR-RMS trial (Sponsored by the University of Birmingham) is an Investigator Initiated Trial which is funded by Cancer Research UK and Bayer AG. The funding is contingent upon having a suitably compliant clinical trial database that is active and ready for use by the end of 2021. Funding is provided to support the trial to be compliant with additional regulations. The trial used an existing clinical trial database (also sourced externally) however upon review, the existing clinical trial database is not suitable for the revised scope of the trial. Therefore, a new clinical trial database that is regulatory compliant, is able to be delivered within a tight timeline and fall within budget is required. The preferred vendor for creating a clinical trial database for this trial is Viedoc TM.Viedoc TM meets the criteria outlined below that are essential for delivering the clinical trial. The company has a track record of delivering clinical trials to registration standard with other academic organisations running clinical trials of this nature (international, paediatric oncology trials with multiple arms) and was independently recommended to the University of Birmingham. Additionally, Viedoc TM is in the process of undergoing a detailed audit of their systems with the University of Birmingham. This is an essential requirement to perform prior to the set-up of an electronic clinical trial database when required for registration standard trials. Viedoc TM have confirmed their ability to deliver the clinical trial database in 2021 and within the budget. The detailed audit of Viedoc TM has also confirmed that it is compliant with the regulations and is therefore suitable for use in the FaR-RMS trial.",
"hasOptions": false
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UKG"
}
],
"deliveryLocation": {
"description": "University of Birmingham, Edgbaston, Birmingham Some work carried out at supplier premises: Uppsala, Sweden"
},
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_OUTSIDE_SCOPE",
"description": "The procurement falls outside the scope of application of the directive"
}
],
"procurementMethodRationale": "The preferred vendor for creating a clinical trial database for this trial is Viedoc TM.Viedoc TM meets the criteria outlined below that are essential for delivering the clinical trial. The company has a track record of delivering clinical trials to registration standard with other academic organisations running clinical trials of this nature (international, paediatric oncology trials with multiple arms) and was independently recommended to the University of Birmingham. Additionally, Viedoc TM is in the process of undergoing a detailed audit of their systems with the University of Birmingham. This is an essential requirement to perform prior to the set-up of an electronic clinical trial database when required for registration standard trials. Viedoc TM have confirmed their ability to deliver the clinical trial database in 2021 and within the budget. The detailed audit of Viedoc TM has also confirmed that it is compliant with the regulations and is therefore suitable for use in the FaR-RMS trial. The following are detailed reasons for the selection of Viedoc TM as a vendor to provide a clinical trial database for FaR-RMS: * Able to perform a 'rescue' mission and align an existing clinical database that is in use into a single database for the study * Able to deliver a live clinical trial database for the study in 2021 * Qualified by the University of Birmingham as a regulatory compliant clinical trial database * Fall under a maximum budget of PS500,000 for the whole clinical trial database"
},
"awards": [
{
"id": "025023-2021-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-30984",
"name": "Viedoc Technologies AB"
}
]
}
],
"parties": [
{
"id": "GB-FTS-534",
"name": "UNIVERSITY OF BIRMINGHAM",
"identifier": {
"legalName": "UNIVERSITY OF BIRMINGHAM"
},
"address": {
"streetAddress": "Edgbaston",
"locality": "BIRMINGHAM",
"region": "UKG31",
"postalCode": "B152TT",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Paul Markham",
"email": "p.markham@bham.ac.uk"
},
"roles": [
"buyer"
],
"details": {
"url": "https://www.birmingham.ac.uk/index.aspx",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "09",
"description": "Education"
}
]
}
},
{
"id": "GB-FTS-30984",
"name": "Viedoc Technologies AB",
"identifier": {
"legalName": "Viedoc Technologies AB"
},
"address": {
"streetAddress": "S:t Persgatan 6",
"locality": "Uppsala",
"region": "SE",
"postalCode": "75320",
"countryName": "Sweden"
},
"roles": [
"supplier"
],
"details": {
"url": "http://www.viedoc.com",
"scale": "large"
}
},
{
"id": "GB-FTS-30985",
"name": "The University of Birmingham",
"identifier": {
"legalName": "The University of Birmingham"
},
"address": {
"streetAddress": "Edgbaston",
"locality": "Birmingham",
"postalCode": "B15 2TT",
"countryName": "United Kingdom"
},
"roles": [
"reviewBody"
]
}
],
"buyer": {
"id": "GB-FTS-534",
"name": "UNIVERSITY OF BIRMINGHAM"
},
"contracts": [
{
"id": "025023-2021-1",
"awardID": "025023-2021-1",
"status": "active",
"value": {
"amount": 500000,
"currency": "GBP"
},
"dateSigned": "2021-10-04T00:00:00+01:00"
}
],
"language": "en"
}